Smoking cigarettes is considered a major global health problem as approximately one in 5 individuals smoke cigarettes daily and are at increased risk for death and disease.
This ACPE-accredited application-based online continuing education program has been designed to prepare pharmacists to serve as reimbursable providers of nicotine replacement therapy and counseling to facilitate smoking cessation. The course begins with a review of the latest CDC guidelines and CA Board of Pharmacy AB1114 legislation.
Dr. Rory Kim guides participants through case-based modules to apply non-pharmacologic and pharmacologic treatments for smoking cessation. This program satisfies the CA Board of Pharmacy requirements for pharmacists to receive reimbursement for the provision of nicotine replacement therapy and smoking cessation counseling under AB1114.
Target Audience: Pharmacists interested in developing expertise in smoking cessation therapeutics
Goals: To provide pharmacists with the knowledge and skills needed to function as a reimbursable provider of tobacco cessation products
Credit: Earn 2.5 hours of continuing education credit
|Rory Kim, PharmD
Clinical Pharmacy & Pharmaceutical Econ and Policy
USC School of Pharmacy
Los Angeles, California
Outline for Smoking Cessation Online CE
Module 1 (Pre-reading): Review of Smoking Cessation Guideline and Protocol for Pharmacists Furnishing Nicotine Replacement Products
Module 2: Smoking cessation overview, review of behavioral interventions, and legislation
Module 3: Comparing NRT, review of efficacy, tolerability, monitoring and counseling, case study on treatment selection
Module 4: Comparing non-nicotine smoking cessation treatments, 2nd case study on treatment selection, use of electronic nicotine delivery systems (ENDS), summary
At the completion of this activity, the participant will be able to:
Describe California’s new legislation regarding smoking cessation and the pharmacist’s role in providing nicotine replacement therapy for patients
Differentiate nicotine replacement therapy product formulations with regards to ease of use, effectiveness, tolerability, and cost
Compare bupropion and varenicline with regards to efficacy, tolerability, dosing, and duration of use when prescribed for tobacco smoking cessation
Given a patient case, propose a treatment plan and timeline for tobacco smoking cessation that includes behavioral interventions, nicotine replacement therapy, and an assessment on whether a prescription smoking product is indicated
General Registration: $75
Special Registration: (approved-preceptor, alumni, QSAD): $50